SCHEMBL7216797

SCHEMBL7216797

CCCOCCOc1ccc(CO)cc1OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.50
S1PR1 P21453 4/20 0.44
S1PR3 Q99500 4/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
S1PR2 O95136 1/20 0.42
LPAR2 Q9HBW0 1/20 0.42
POLB P06746 1/20 0.42
CASP6 P55212 1/20 0.42
ALDH1A1 P00352 4/20 0.40
LMNA P02545 2/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.40
CALM1 P0DP23 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038976 0.85 MAPT (0.49) HTTS1PR1S1PR3POLBALDH1A1
SCHEMBL697888 0.85 HTT (0.61) HTTS1PR1S1PR3POLBALDH1A1
SCHEMBL18433012 0.82 KMT2A (0.43) L3MBTL1POLBALDH1A1LMNAKMT2A
SCHEMBL11470313 0.81 HTT (0.52) HTTS1PR1S1PR3L3MBTL1S1PR2
SCHEMBL7043742 0.80 BIRC5 (0.49) HTTS1PR1S1PR3S1PR2LPAR2
SCHEMBL15929473 0.79 MEN1 (0.58) HTTL3MBTL1ALDH1A1LMNAKMT2A
SCHEMBL8845989 0.79 S1PR1 (0.49) HTTS1PR1S1PR3S1PR2LPAR2
SCHEMBL18433013 0.78 MEN1 (0.53) HTTS1PR1ALDH1A1LMNAKMT2A
SCHEMBL7922046 0.78 HPGD (0.48) HTTL3MBTL1POLBCASP6ALDH1A1
SCHEMBL10996676 0.78 S1PR1 (0.51) HTTS1PR1S1PR3S1PR2LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed